by European Society of Cardiology Credit: Pixabay/CC0 Public Domain Finerenone does not reduce the risk of all-cause death in patients with type 2 diabetes and kidney disease but does lower the likelihood of sudden cardiac death, according to late breaking research presented in a Hot Line session on 29 August at ESC Congress 2022. It is estimated...
